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INTRODUCTION 
Diabetic retinopathy is one of the most prevalent and 
leading cause of blindness among adult aged  20-74 
years. Primary care physicians (PCPs) are front-line 
care givers for patients with diabetes and are most 
important in counselling the patients about proper 
treatment and complications regarding diabetic 
retinopathy. Therefore, understanding ocular 
manifestations of diabetes and knowing the screening 
guidelines can impact timeliness of referrals to 
ophthalmology by PCPs.
1,2
  
Blindness caused by diabetic retinopathy is potentially 
preventable. Early detection and treatment of vision 
threatening changes in the retina can lead to a better 
visual out come. The primary care physician has access 
to all the diabetic population as the patients attend the 
primary care hospitals for their medical treatment. 
Ophthalmologists can provide specialized services like 
laser and vitrectomy. Regular screening and prompt 
referral by primary care physician can only prevent the 
blinding complication.
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Pathophysiology  
Diabetic retinopathy is a micro vascular disease. It 
affects the capillaries of the retina and later the larger 
blood vessels are also affected.  
Elevated blood glucose causes certain changes in the 
blood which in turn damage the vessel wall leading to 
various pathological lesions seen in the fundus picture. 
Several biochemical changes have been implicated 
which influence the disease process through changes in 
the cellular metabolism, signalling and growth factors. 
These include polyol accumulation, protein kinase 
activation, oxidative stress and accumulation of 
advanced glycation end products. 
Alteration in the cellular components  like increased 
agglutination of platelets leads to slowing of the blood 
stream. Protein kinase C activation leads to loss of 
pericytes, damage to the basement membrane and is 
responsible for the appearance of micro aneurysms 
which are a pouch like projections of the capillary 
wall. They are seen as pinpoint, red dot like lesions 
seen in the posterior pole of retina .
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ABSTRACT 
Objective: The  objective of   this study  is  importance  of  primary care physician in screening  diabetic  retinopahy   patients 
Material and  Methods  : Patients of  type-2  diabetes mellitus  attending  diabetic clinic in melaka  manipal  medical college , 
malaysia were  prospectively  reviewed. Risk factors associated   in  study  population were  assessed  by  biochemical 
parameters, clinical examination  , retinal photographs  and  referred  to  ophthalmology  clinic. 
Results: The  prevalence of  non  proliferative and  proliferative diabetic retinopathy  with  type-2 diabetic  patients  was 17%  
and 1%   with  history of decreased  in vision  above age group of  50 years  . In addition  the  risk  factors  in the  study group  
associated with  the  development  of diabetic retinopathy  are   uncontrolled  HbA1c  levels (  27%) , high BMI  (38%  ),  
increased total cholesterol (9% )  , uncontrolled fasting blood sugar levels (47%),   and  increased  duration of diabetes.  
Conclusion: Diabetic  retinopahy  is highly prevalent in patients with type-2 diabetes mellitus. Our findings  indicates  primary 
care physicians  are   well educated  in regards to diabetic eye disease  and  in identification  of  risk factors due  to  number of  
years experience. 
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As the changes become longstanding endothelial cells 
are damaged resulting in disruption of blood retinal 
barrier. Leakage of large molecules like blood elements, 
proteins and lipids results in dot blot haemorrhages, 
retinal edema and thickening. The edema  disappears 
leaving behind the hard exudates, which can be 
observed as yellowish well defined lesions often seen as 
clumps. These changes constitute non proliferative 
diabetic retinopathy and as long as macula is not 
involved the patient may not have any visual  
complaints although severe changes can occur in other 
parts of retina with normal vision. Similar changes 
occurring near the macula result in defective vision and 
are classified as diabetic maculopathy.
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MATERIAL AND METHODS 
A  population  based  case control study was done  over a  
period  of  1 year in  melaka  manipal  medical college,  
malaysia  patients  attending  the  out-patient  department  
with history of diabetes. Permission  from  institutional  
review  board and written  informed  consent  was  
obtained  from  subjects  as  per   helsinki declaration. 
300 patients ,  particiapated in the study group and all  
had  type-2 diabetes as defined by the absence  of  ketosis  
and adequate insulin reserve. Individuals aged less than 
40 years and duration of  diabetes  less than 5 years , 
children less than 10 years  were excluded from the study 
because of  less  risk of  retinopahy. Age  group  50 years 
and  above were  included  in the  study group. 
Clinical and biochemical parameters  
Anthropometric  measurements including weight, 
height, and  waist measurements were obtained  using 
standardized techniques.  
The body mass index (BMI) was calculated by formula: 
weight in kilograms divided  by height  in  meters 
square. Blood pressure  was  recorded in the sitting  
position in  the  right arm  to  the  nearest 2 mmHg with 
a  mercury sphygmomanometer.  
Fasting  capillary blood glucose was  determined with a 
glucose meter (One Touch Basic; LifeScan, Johnson & 
Johnson, Milpitas, CA)  in all subjects after ensuring 8 
hours of overnight  fasting  for estimation of plasma 
glucose and serum lipids with an autoanalyzer (Hitachi 
912; Roche Diagnostics GmbH, Mannheim, Germany) 
using kits  supplied  by  the manufacturer. Glycated  
haemoglobin (HbA1c)  was measured by high pressure 
liquid chromatography (HPLC),  using  the  variant  
machine (Bio-Rad, Hercules, CA).  
Ocular examination 
Visual acuity was  recorded  with  an  illuminated  
snellen chart and visual acuity was documented  
separately for each eye.  
Retinal studies 
Retinal examination was performed with direct 
ophthalmoscopy after dilating the pupils with 1 drop of 
phenylephrine (5%) and tropicamide (1%) in both eyes, 
until the best possible mydriasis was  obtained. 
The  minimum criterion for diagnosis of diabetic 
retinopathy  was the presence of at least one definite  
microaneurysm  in any  field photographed. 
Photographs  were assessed and assigned a retinopathy 
level, and the final diagnosis for each patient was 
determined from the grading of  the  worse eye  
according to  the ETDRS criteria for severity of disease 
in the individual eye.
6
   
RESULTS 
Of  300 cases known diabetic patients , 17%  had  non 
proliferative retinopathy (NPDR), 1%  had  proliferative 
retinopathy with  33% ˂5 years , 40% > 5-10 years,  
20% >10 years duration 
 
Table 1: Prevalence of diabetic retinopathy in the study group 
 Number of cases Percentage  
Nonproliferative retinopathy                   50  17% 
Proliferative retinopathy                    4   1% 
 
Table 2: Risk factors associated in study population 
 Number of cases  Percentage  
Uncontrolled HbA1c           80         27% 
Body Mass index(BMI)          115         38% 
Increased total Cholesterol           26           9% 
Uncontrolled fasting blood sugar          140          47% 
Age (>50years)          210            70% 
Duration of diabetes 
 ˂5years           100           33% 
5- 10 years           120           40% 
>10years            60           20% 
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DISCUSSION 
Diabetes and blindness caused by diabetic retinopathy is 
a major community health problem. The problem is 
ever increasing as the diabetic population and the 
duration of diabetes is increasing. 
Modification of  the   associated  risk  factors as well as 
early detection and  treatment  of sight-threatening  
diabetic retinopathy can prevent blindness. Clinical 
practice guidelines recommend  annual eye screening 
for patients with diabetes mellitus.  
The major risk  factors  for  diabetic retinopathy in this 
study were duration of diabetes and degree of  glycemic 
control, consistent  with  findings  in previous 
studies.
7,8,9
 
The  prevalence of  non  proliferative and  proliferative 
diabetic retinopathy  with  type-2 diabetic  patients  
(Table 1) was 17% (50 cases/300) and 1%  (4 
cases/300) from age 50 and above. In addition  the  risk  
factors  in the  study group  (Table 2) associated with  
the  development  of diabetic retinopathy  are   
uncontrolled  HbA1c  levels   27% (80), high BMI  38%  
(115) , increased total cholesterol 9% (26)  , 
uncontrolled fasting blood sugar levels 47%(140),  age 
group above 50 years 70% (210),  duration of diabetes 
<5 years 33% (100),   5 - 10 years 40% (120)  and   >10 
years 20% (60). 
The  strengths of  this  study  are  that it was based on  
retinal photography and standard grading techniques  
and  the study  included  a  large  representative 
population. 
CONCLUSION 
Adherence  to  eye  screening guidelines and the prompt 
referral of  sight  threatening diabetic  retinopathy are 
essential  in order to  reduce the incidence of  blindness 
among patients  with diabetes mellitus. This emphasizes 
the need for routine retinal screening of diabetic 
individuals to detect diabetic retinopathy in the early 
stages. 
Our findings reveal that regardless of the type of 
primary care training or the number of years of 
experience, primary care physicians are well educated 
in regards to diabetic eye disease. If our findings are 
generalizable to all primary care physicians, then the 
lack of examinations are likely due to an issue other 
than physician knowledge. Thus other avenues of 
investigation into the etiology of this problem such as 
examining physician compliance, patient 
communication, patient compliance or other barriers to 
healthcare need to be explored. 
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